Fabrication and Characterization of Phyllanthus Emblica Extract-Polyvinyl Alcohol/Carboxymethyl Cellulose Sodium Antioxidant Hydrogel and Its Application in Wound Healing
2024

Antioxidant Hydrogel from Phyllanthus Emblica for Wound Healing

Sample size: 12 publication 10 minutes Evidence: high

Author Information

Author(s): Huang Shanqin, Li Shanglun, Li Guoyan, Wang Chenyu, Guo Xiaohan, Zhang Jing, Liu Jing, Xu Ying, Wang Yanchun, Quaglia Fabiana

Primary Institution: College of Pharmacy, Jiangsu University, Zhenjiang, China

Hypothesis

The study aims to develop a hydrogel system incorporating Phyllanthus emblica extract to enhance wound healing through its antioxidant properties.

Conclusion

The AEPE composite hydrogel demonstrated strong antioxidant characteristics and significant wound healing potential.

Supporting Evidence

  • The hydrogel matrix containing 12% PVA and 1% CMC-Na exhibited excellent physicochemical properties.
  • The optimized AEPE composite hydrogel enabled sustained drug release over a 24 h period.
  • In a mouse dorsal wound healing model, the AEPE composite hydrogel showed pronounced anti-inflammatory and antioxidation effects.
  • The AEPE hydrogel demonstrated the strongest potential in promoting cell migration.
  • Histological analysis revealed improved collagen deposition and tissue recovery in the AEPE hydrogel group.

Takeaway

This study created a special gel from a plant that helps wounds heal faster and better because it fights off bad stuff that slows healing.

Methodology

The study involved optimizing the extraction of Phyllanthus emblica, evaluating the antioxidant activity of the extract, and testing the hydrogel's performance in wound healing using BALB/C mice.

Limitations

The study primarily focused on in vivo models, and further research is needed to explore long-term effects and clinical applications.

Participant Demographics

BALB/C mice (male, 3–4 weeks old, weighing between 18 and 22 g)

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/pharmaceutics16121531

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication